Advice

Medicine Discontinued

The product license holder of rupatadine (Rupafin) advised that from 31 March 2015 this medicine will be discontinued in the UK.

 

Medicine details

Medicine name:
rupatadine (Rupafin)
SMC ID:
612/10
Indication:
Symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria in adults and adolescents (over 12 years of age).
Pharmaceutical company
GlaxoSmithKline UK Ltd
BNF chapter
Respiratory system
Submission type
Non submission
Status
Withdrawn
Date advice published:
08 March 2010
Additional notes

The product license holder of rupatadine (Rupafin) advised that from 31 March 2015 this medicine will be discontinued in the UK.

https://www.prescriber.org.uk/2015/04/rupatadine-discontinued/